Retinal Degenerative Diseases

  • Matthew M. LaVail
  • John D. Ash
  • Robert E. Anderson
  • Joe G. Hollyfield
  • Christian Grimm

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 723)

Table of contents

  1. Front Matter
    Pages i-lxiv
  2. AMD: Basic Mechanisms, Inflammation and Immunity

    1. Front Matter
      Pages 1-1
    2. Alessandro Iannaccone, Indira Neeli, Pratheebha Krishnamurthy, Nataliya I. Lenchik, Haibao Wan, Ivan C. Gerling et al.
      Pages 11-16
    3. Kannan Kunchithapautham, Mausumi Bandyopadhyay, Mohammad Dahrouj, Joshua M. Thurman, Bärbel Rohrer
      Pages 23-30
    4. Matt Rutar, Riccardo Natoli, Jan Provis, Krisztina Valter
      Pages 31-36
    5. Elod Kortvely, Marius Ueffing
      Pages 61-66
    6. Julien Bruban, Virginie Dinet, Frédéric Mascarelli
      Pages 67-74
    7. Zsolt Ablonczy, Danielle B. Gutierrez, Angus C. Grey, Kevin L. Schey, Rosalie K. Crouch
      Pages 75-81
    8. Sayak K. Mitter, Haripriya Vittal Rao, Xiaoping Qi, Jun Cai, Andrew Sugrue, William A. Dunn Jr. et al.
      Pages 83-90
  3. Neuroprotection, Drugs and Novel Protective Therapies

    1. Front Matter
      Pages 91-91
    2. Rong Wen, Weng Tao, Lingyu Luo, Deqiang Huang, Konrad Kauper, Paul Stabila et al.
      Pages 93-99
    3. Marisa A. Cubilla, Mauricio M. Castañeda, Tomás P. Bachor, Angela M. Suburo
      Pages 101-106
    4. Javier Sancho-Pelluz, François Paquet-Durand
      Pages 107-113
    5. Machelle T. Pardue, Moon K. Kim, Tiffany A. Walker, Amanda E. Faulkner, Alan Y. Chow, Vincent T. Ciavatta
      Pages 115-120

About these proceedings


This book will contain the proceedings of the XIV International Symposium on Retinal Degeneration (RD2010), held July 13-17, 2010, in Mont-Tremblant, Quebec, Canada. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.

Editors and affiliations

  • Matthew M. LaVail
    • 1
  • John D. Ash
    • 2
  • Robert E. Anderson
    • 3
  • Joe G. Hollyfield
    • 4
  • Christian Grimm
    • 5
  1. 1.University of California, San FranciscoSan FranciscoUSA
  2. 2.University of Oklahoma Health Sciences COklahoma CityUSA
  3. 3.Health Science Center, Dean A. McGee Eye Inst.University of OklahomaOKLAHOMA CITYUSA
  4. 4.Division of OphthalmologyCole Eye Institute at the Cleveland ClinClevelandUSA
  5. 5.Experimental OphthalmologyUniversity of ZurichZURICHSwitzerland

Bibliographic information

  • DOI
  • Copyright Information Springer Science+Business Media, LLC 2012
  • Publisher Name Springer, Boston, MA
  • eBook Packages Biomedical and Life Sciences
  • Print ISBN 978-1-4614-0630-3
  • Online ISBN 978-1-4614-0631-0
  • Series Print ISSN 0065-2598
  • About this book